Evidence map›Paper›PMID 27129302›Full record

ArticleBioscience reports2016

HEY1 functions are regulated by its phosphorylation at Ser-68.

Irene López-Mateo, Amaia Arruabarrena-Aristorena, Cristina Artaza-Irigaray, Juan A López, Enrique Calvo, Borja Belandia

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Large-conductance CaThe Journal of physiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Irene López-MateoDepartment of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain.
Amaia Arruabarrena-AristorenaProteomics Unit, CIC bioGUNE, Bizkaia Technology Park, 48160 Derio, Spain.
Cristina Artaza-IrigarayDivisión de Inmunología, Centro de Investigación Biomédica de Occidente-IMSS, Sierra Mojada 800, 44340 Guadalajara, Jalisco, Mexico.
Juan A LópezUnidad de Proteomica, Centro Nacional de Investigaciones Cardiovasculares, CNIC, 28029 Madrid, Spain.
Enrique CalvoUnidad de Proteomica, Centro Nacional de Investigaciones Cardiovasculares, CNIC, 28029 Madrid, Spain.
Borja BelandiaDepartment of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain bbelandia@iib.uam.es.
Spanish National Centre for Cardiovascular Research · ESUniversidad Autónoma de Madrid · ESCIC bioGUNE · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HEY1 (hairy/enhancer-of-split related with YRPW motif 1) is a member of the basic helix-loop-helix-orange (bHLH-O) family of transcription repressors that mediate Notch signalling. HEY1 acts as a positive regulator of the tumour suppressor p53 via still unknown mechanisms. A MALDI-TOF/TOF MS analysis has uncovered a novel HEY1 regulatory phosphorylation event at Ser-68. Strikingly, this single phosphorylation event controls HEY1 stability and function: simulation of HEY1 Ser-68 phosphorylation increases HEY1 protein stability but inhibits its ability to enhance p53 transcriptional activity. Unlike wild-type HEY1, expression of the phosphomimetic mutant HEY1-S68D failed to induce p53-dependent cell cycle arrest and it did not sensitize U2OS cells to p53-activating chemotherapeutic drugs. We have identified two related kinases, STK38 (serine/threonine kinase 38) and STK38L (serine/threonine kinase 38 like), which interact with and phosphorylate HEY1 at Ser-68. HEY1 is phosphorylated at Ser-68 during mitosis and it accumulates in the centrosomes of mitotic cells, suggesting a possible integration of HEY1-dependent signalling in centrosome function. Moreover, HEY1 interacts with a subset of p53-activating ribosomal proteins. Ribosomal stress causes HEY1 relocalization from the nucleoplasm to perinucleolar structures termed nucleolar caps. HEY1 interacts physically with at least one of the ribosomal proteins, RPL11, and both proteins cooperate in the inhibition of MDM2-mediated p53 degradation resulting in a synergistic positive effect on p53 transcriptional activity. HEY1 itself also interacts directly with MDM2 and it is subjected to MDM2-mediated degradation. Simulation of HEY1 Ser-68 phosphorylation prevents its interaction with p53, RPL11 and MDM2 and abolishes HEY1 migration to nucleolar caps upon ribosomal stress. Our findings uncover a novel mechanism for cross-talk between Notch signalling and nucleolar stress.

Indexed as

Amino Acid SequenceBasic Helix-Loop-Helix ProteinsCell Cycle CheckpointsCell Cycle ProteinsCell NucleusHumansPhosphorylationProtein BindingProtein Serine-Threonine KinasesProteolysisProto-Oncogene Proteins c-mdm2Receptors, NotchRibosomal ProteinsRibosomesSerineSignal TransductionBasic Helix-Loop-Helix ProteinsCell Cycle ProteinsHEY1 protein, humanMDM2 protein, humanProtein Serine-Threonine KinasesProto-Oncogene Proteins c-mdm2Receptors, Notchribosomal protein L11Ribosomal ProteinsSerineSTK38L protein, humanSTK38 protein, humanTP53 protein, humanTumor Suppressor Protein p53centrosomeHEY1p53phosphorylationribosomal stressSTK38

Identifiers

PMID27129302
PMCPMC5293587
OpenAlexW2343915732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.